Navigation Links
Vestaron Corporation Announces New Leadership

KALAMAZOO, Mich., April 28, 2011 /PRNewswire/ -- Vestaron Corporation, a Kalamazoo-based company developing the next- generation of environmentally conscious insecticide products, announced today that John Sorenson, Ph.D., will serve as interim President and Chief Executive Officer. The Board of Directors thanks John McIntyre for his years of service leading to the development of breakthrough insecticides for agriculture.

"John's scientific leadership has been just what Vestaron needed to get us to where we are today," said Jim Schultz of Open Prairie Ventures, a major investor and board director. "We wish John well in his next endeavor."

John Sorenson, Ph.D., will serve as interim President and CEO and continue his current role as Chairman of the Board of Directors. Elin Miller will continue her role as Vice Chairman while the company searches for a new CEO. Vestaron has engaged Kincannon & Reed for the search, which has already begun.

"This is a critical and exciting time for our company with upcoming field trials this summer, which will set the stage for our registration submission. I am thrilled to take the helm," said Dr. Sorenson. Dr. Sorenson has a broad background in plant biotechnology, both in academe and in the private sector. In addition to serving as President of Biotechnology for Syngenta, he also served as President of Syngenta Seed, Inc. and held several positions in the Asgrow Seed Company. Sorenson began his career as Assistant and Associate Professor of Genetics at North Carolina State University.

Vestaron Corporation is a Kalamazoo, Mich.-based company that has been working for the past few years to develop insecticide products that are harmless to humans and other mammals and are environmentally conscious. Using the polypeptides found in spider venom, Vestaron which was formerly known as Venomix, Inc., has reported that its tests are seeing positive results against mosquitoes, caterpillars, flies and cockroaches.

Vestaron Corporation is a portfolio company of Open Prairie Ventures, an Effingham, Illinois- based venture capital firm with offices in Kalamazoo and Southwest Michigan First Life Science Fund.

SOURCE Vestaron Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Mitsubishi Chemical Corporation Signs Memorandum of Understanding for Strategic Partnership With Genomatica for Sustainable Chemicals in Asia
2. Every Day is Earth Day for Yulex Corporation
3. Veteran Wall Street Securities Analyst Reports on Health Discovery Corporation
4. CryoLife Amends Tender Offer Related to its Proposed Acquisition of Cardiogenesis Corporation
5. delSECUR CORPORATION Announces Its Dissolution; and the Distribution of Its Asset to Its Lenders and Shareholders of the Corporation
6. Techne Corporation Announces Acquisition
7. Ther-Rx Corporation Commits to Take Action Regarding Makena™ Pricing
8. SARcode Corporation to Present Phase 2 Clinical Data for Dry Eye Candidate at the ARVO2011 Annual Meeting
9. United Therapeutics Corporation Completes Enrollment of FREEDOM-C(2) Trial
10. Volcano Corporation Presentation at Roth Capital Conference to be Webcast
11. Sanford Rose Associates® - Minneapolis Fills Key Management Position for the Micromedics Operation of Nordson Corporation
Post Your Comments:
(Date:11/25/2015)... , November 26, 2015 ... Biobanking Market 2016 - 2020 report analyzes that ... integrity and quality in long-term samples, minimizing manual ... cost-effectiveness. Automation minimizes manual errors such as mislabeling ... efficiency. Further, it plays a vital role in ...
(Date:11/25/2015)... -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced today ... Neurocrine Biosciences, will be presenting at the 27th Annual ... . .   Listeners ... prior to the presentation to download or install any ... available on the website approximately one hour after the ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and ... early in their initial angel funding process. Now, they are paying it forward ... make early stage investments in the microbiome space. In this, they join ...
(Date:11/24/2015)... 24, 2015 /CNW/ - iCo Therapeutics ("iCo" or "the ... results for the quarter ended September 30, 2015. ... dollars and presented under International Financial Reporting Standards ... ," said Andrew Rae , President & ... are not only value enriching for this clinical ...
Breaking Biology Technology:
(Date:10/29/2015)... , Oct. 29, 2015   MedNet Solutions ... the entire spectrum of clinical research, is pleased to ... High Tech Association (MHTA) as one of only three ... the "Software – Small and Growing" category. The Tekne Awards ... who have shown superior technology innovation and leadership. ...
(Date:10/29/2015)... 29, 2015  Rubicon Genomics, Inc., today announced ... of its DNA library preparation products, including the ... ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has been optimized ... NGS libraries for liquid biopsies--the analysis of cell-free ... applications in cancer and other conditions. Eurofins Scientific ...
(Date:10/29/2015)... , Oct. 29, 2015 Today, ... a partnership with 2XU, a global leader in ... a smart hat with advanced bio-sensing technology. The ... athletes to monitor key biometrics to improve overall ... partnership, the two companies will bring together the most ...
Breaking Biology News(10 mins):